Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Mogamulizumab Combinations in Patients with Relapsing/Refractory Adult T-Cell Leukemia/Lymphoma (r/r ATLL)

Maya D. Srinivasan, Christopher Dittus, Areej El-Jawahri, Salvia Jain, Anthony Shelton, John Mark Sloan

Blood (2024) 144 (Supplement 1): 6405.

https://doi.org/10.1182/blood-2024-205425

Published: 2024

Journal Articles

A Phase 2 Trial Investigating Epcoritamab in Patients with Previously Treated Waldenstrom Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (WM-NET3)

Gottfried von Keudell, Emma K Logan, Robert A. Redd, Shayna R Sarosiek, Andrew R. Branagan, Larry D Anderson, Jr., Christopher Dittus, Steven P. Treon, Jorge J. Castillo

Blood (2024) 144 (Supplement 1): 6294.

https://doi.org/10.1182/blood-2024-206415

Published: 2024

Journal Articles

Improving Outcomes in Plasmablastic Lymphoma: A Multicenter Experience from an American Cohort

Blood (2024) 144 (Supplement 1): 573.

https://doi.org/10.1182/blood-2024-198008

Published: 2024

Journal Articles

Asparaginase Treatment Patterns, Toxicity, and Outcomes Among Patients with Extranodal NK/T-Cell Lymphoma: A North American Multicenter Retrospective Cohort Study

Blood (2024) 144 (Supplement 1): 1690.

https://doi.org/10.1182/blood-2024-211424

Published: 2024

Journal Articles

CD30.CAR-T Cells Co-Expressing the CCR4 Chemokine Receptor in Relapsed/Refractory Hodgkin Lymphoma

Natalie Grover, Dominic Moore, Anastasia Ivanova, Anne W Beaven, Christopher Dittus, Catherine Joyce Arago Cheng, Kelly Hoye, Caroline Babinec, Faith Brianne Buchanan, Angela Denise Spruill, Ashley Zanter, John West, J. Kaitlin Morrison, Paul Armistead, Kimberly A. Kasow, Jonathan Serody, Gianpietro Dotti, Barbara Savoldo

Blood (2024) 144 (Supplement 1): 919.

https://doi.org/10.1182/blood-2024-200932

Published: 2024

Journal Articles

Final Results of a Multicenter Pilot Study Evaluating Brentuximab Vedotin with Cyclophosphamide, Doxorubicin, Etoposide, and Prednisone (BV-CHEP) for the Treatment of Aggressive Adult T-Cell Leukemia/Lymphoma

Christopher Dittus, Matthew Weinstock, Jeffrey A. Barnes, Jose Sandoval-Sus, Natalie S. Grover, Anne Beaven, Xianming Tan, Areej El-Jawahri, Shayna R Sarosiek, John Mark Sloan

Blood (2023) 142 (Supplement 1): 1692.

https://doi.org/10.1182/blood-2023-173822

Published: 2023

Journal Articles

High-Dose Methotrexate Containing Induction Chemotherapy Followed By Nivolumab Consolidation in Older (≥ 65) Patients with Previously Untreated Primary CNS Lymphoma

Steven I. Park, Lakshmi Nayak, Danielle Boselli, Raphael E Steiner, Ashley L Sumrall, Nazanin K Majd, Xhevahire Begic, Sarah Norek, Christopher Dittus

Blood (2023) 142 (Supplement 1): 1723.

https://doi.org/10.1182/blood-2023-179526

Published: 2023

Journal Articles

Clinical Activity of Anti-PD-1 Therapy Following CD30 CAR-T Cell Therapy in Relapsed Hodgkin Lymphoma

Timothy J. Voorhees, Anne W. Beaven, Christopher Dittus, George E Hucks, J. Kaitlin Morrison, Catherine Joyce Arago Cheng, Tammy Cavallo, Steven I. Park, Gianpietro Dotti, Jonathan S. Serody, Barbara Savoldo, Natalie S. Grover

Blood (2022) 140 (Supplement 1): 12723–12724.

https://doi.org/10.1182/blood-2022-156660

Published: 2022

Journal Articles

A Pilot Study Evaluating Acalabrutinib for the Treatment of Relapsed/Refractory Primary and Secondary Central Nervous System Lymphomas

Christopher Dittus, Roy Ervin Strowd III, Kelly Hoye, Xianming Tan, Jordan Miller, Celeste Bello, Amir Khandani, Anne W. Beaven

Blood (2022) 140 (Supplement 1): 6616–6617.

https://doi.org/10.1182/blood-2022-165139

Published: 2022

Journal Articles

A Registry-Based Geodemographic Assessment of Non-Hodgkin Lymphoma Subtypes in North Carolina

Jennifer Morgan, Jennifer S Smith, Chandrika Rao, Dominic T. Moore, Christopher Dittus

Blood (2021) 138 (Supplement 1): 2503.

https://doi.org/10.1182/blood-2021-150043

Published: 2021

Journal Articles

CD30-Directed CAR-T Cells Co-Expressing CCR4 in Relapsed/Refractory Hodgkin Lymphoma and CD30+ Cutaneous T Cell Lymphoma

Natalie S Grover, Anastasia Ivanova, Dominic T. Moore, Catherine Joyce Arago Cheng, Caroline Babinec, John West, Tammy Cavallo, J. Kaitlin Morrison, Faith Brianne Buchanan, Edith Bowers, Christopher Dittus, Anne W. Beaven, Gianpietro Dotti, Jonathan S. Serody, Barbara Savoldo

Blood (2021) 138 (Supplement 1): 742.

https://doi.org/10.1182/blood-2021-148102

Published: 2021

Journal Articles

Interim Results of a Multicenter Pilot Study Evaluating Brentuximab Vedotin with Cyclophosphamide, Doxorubicin, Etoposide, and Prednisone (BV-CHEP) for the Treatment of Aggressive Adult T-Cell Leukemia/Lymphoma

Christopher Dittus, Matthew J Weinstock, Jeffrey A Barnes, Jose Sandoval-Sus, Xianming Tan, Xinyi Zhang, Areej El-Jawahri, Shayna Sarosiek, John Mark Sloan

Blood (2021) 138 (Supplement 1): 1395.

https://doi.org/10.1182/blood-2021-144422

Published: 2021

Journal Articles

A Multicenter, Real World Analysis of Primary Central Nervous System Lymphoma in Those with and without Human Immunodeficiency Virus

Christopher Dittus, Natalie S Grover, Tarsheen Sethi, Jonathon B. Cohen, Alfredo Voloschin, Janhvi Rabadey, Xianming Tan, Anne W. Beaven, Steven I. Park

Blood (2021) 138 (Supplement 1): 1457.

https://doi.org/10.1182/blood-2021-145133

Published: 2021

Journal Articles

Incidence and Characteristics of CD20 Monoclonal Antibody-Induced Interstitial Pneumonitis

Jacob Newton Stein, Natalie S Grover, Janhvi Rabadey, Christopher Dittus

Blood (2021) 138 (Supplement 1): 4567.

https://doi.org/10.1182/blood-2021-149829

Published: 2021

Journal Articles

High Risk Cytogenetic and Immunohistochemistry Findings in Monomorphic Post-Transplant Lymphoproliferative Disorder Following Solid Organ Transplant - a Single Center Experience

Timothy J Voorhees, MD, Natalie S Grover, MD, Jonathan Galeotti, MD MS, Nathan D Montgomery, MD, Dominic T. Moore, MPH, MS, Anne Beaven, MD, Christopher Dittus, DO

Blood (2019) 134 (Supplement_1): 2915.

https://doi.org/10.1182/blood-2019-126228

Published: 2019

Journal Articles

A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphoma

Peter Martin, Nancy L. Bartlett, Kristie A. Blum, Steven Park, Kami Maddocks, Jia Ruan, LeAnn Ridling, Christopher Dittus, Zhengming Chen, Xiangao Huang, Giorgio Inghirami, Maurizio DiLiberto, Selina Chen-Kiang, John P. Leonard

Blood (2019) 133 (11): 1201–1204.

https://doi.org/10.1182/blood-2018-11-886457

Published: 2019

Journal Articles

Frequency of MYC Overexpression and MYC-BCL2 Double Expression (DEL) in Localized Diffuse Large B-Cell Lymphoma (DLBCL) at a Large Academic Cancer Center

Stephanie Ryanne Corder, BS, Ankit Agarwal, MD MBA, Jonathan Galeotti, MD MS, Xianming Tan, PhD, Natalie S Grover, MD, Christopher Dittus, DO

Blood (2018) 132 (Supplement 1): 4223.

https://doi.org/10.1182/blood-2018-99-111902

Published: 2018

Journal Articles

Clinical Responses to CAR.CD30-T Cells in Patients with CD30+ Lymphomas Relapsed after Multiple Treatments Including Brentuximab Vedotin

Blood (2018) 132 (Supplement 1): 681.

https://doi.org/10.1182/blood-2018-99-113534

Published: 2018

Journal Articles

A Retrospective Study on Prephase Therapy Prior to Definitive Multiagent Chemotherapy in Aggressive Lymphomas

Luis E Malpica Castillo, MD, Jonathan Galeotti, MD MS, Natalie S Grover, MD, Xianming Tan, PhD, Stephen Clark, PharmD, Hyman Muss, MD, Christopher Dittus, DO

Blood (2018) 132 (Supplement 1): 2981.

https://doi.org/10.1182/blood-2018-99-116672

Published: 2018

Journal Articles

Leishmania amastigotes visualized on bone marrow aspirate in a leishmaniasis and HIV coinfected patient presenting with pancytopenia

Christopher Dittus, Dana Semmel

Blood (2013) 122 (26): 4162.

https://doi.org/10.1182/blood-2013-08-519306

Published: 2013

NARROW

Mogamulizumab Combinations in Patients with Relapsing/Refractory Adult T-Cell Leukemia/Lymphoma (r/r ATLL)

A Phase 2 Trial Investigating Epcoritamab in Patients with Previously Treated Waldenstrom Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (WM-NET3)

Improving Outcomes in Plasmablastic Lymphoma: A Multicenter Experience from an American Cohort

Asparaginase Treatment Patterns, Toxicity, and Outcomes Among Patients with Extranodal NK/T-Cell Lymphoma: A North American Multicenter Retrospective Cohort Study

CD30.CAR-T Cells Co-Expressing the CCR4 Chemokine Receptor in Relapsed/Refractory Hodgkin Lymphoma

Final Results of a Multicenter Pilot Study Evaluating Brentuximab Vedotin with Cyclophosphamide, Doxorubicin, Etoposide, and Prednisone (BV-CHEP) for the Treatment of Aggressive Adult T-Cell Leukemia/Lymphoma

High-Dose Methotrexate Containing Induction Chemotherapy Followed By Nivolumab Consolidation in Older (≥ 65) Patients with Previously Untreated Primary CNS Lymphoma

Clinical Activity of Anti-PD-1 Therapy Following CD30 CAR-T Cell Therapy in Relapsed Hodgkin Lymphoma

A Pilot Study Evaluating Acalabrutinib for the Treatment of Relapsed/Refractory Primary and Secondary Central Nervous System Lymphomas

A Registry-Based Geodemographic Assessment of Non-Hodgkin Lymphoma Subtypes in North Carolina

CD30-Directed CAR-T Cells Co-Expressing CCR4 in Relapsed/Refractory Hodgkin Lymphoma and CD30+ Cutaneous T Cell Lymphoma

Interim Results of a Multicenter Pilot Study Evaluating Brentuximab Vedotin with Cyclophosphamide, Doxorubicin, Etoposide, and Prednisone (BV-CHEP) for the Treatment of Aggressive Adult T-Cell Leukemia/Lymphoma

A Multicenter, Real World Analysis of Primary Central Nervous System Lymphoma in Those with and without Human Immunodeficiency Virus

Incidence and Characteristics of CD20 Monoclonal Antibody-Induced Interstitial Pneumonitis

High Risk Cytogenetic and Immunohistochemistry Findings in Monomorphic Post-Transplant Lymphoproliferative Disorder Following Solid Organ Transplant - a Single Center Experience

A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphoma

Frequency of MYC Overexpression and MYC-BCL2 Double Expression (DEL) in Localized Diffuse Large B-Cell Lymphoma (DLBCL) at a Large Academic Cancer Center

Clinical Responses to CAR.CD30-T Cells in Patients with CD30+ Lymphomas Relapsed after Multiple Treatments Including Brentuximab Vedotin

A Retrospective Study on Prephase Therapy Prior to Definitive Multiagent Chemotherapy in Aggressive Lymphomas

Leishmania amastigotes visualized on bone marrow aspirate in a leishmaniasis and HIV coinfected patient presenting with pancytopenia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only